LIV-2008

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLIV-2008
Drug Alias NameLIV-2008
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTumor-associated calcium signal transducer 2 inhibitors
TargetsTumor-associated calcium signal transducer 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLivTech Inc
China Registration ClassN/A

Develop Information

Active CompaniesLivTech Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A